National Institute of Neurological Disorders and Stroke, 53488-53489 [2018-23032]
Download as PDF
<![CDATA[
53488
Federal Register / Vol. 83, No. 205 / Tuesday, October 23, 2018 / Notices
Request (ICR), described below, to the
Office of Management and Budget
(OMB). Prior to submitting the ICR to
OMB, HRSA seeks comments from the
public regarding the burden estimate,
below, or any other aspect of the ICR.
DATES: Comments on this ICR must be
received no later than December 24,
2018.
Submit your comments to
paperwork@hrsa.gov or mail the HRSA
Information Collection Clearance
Officer, Room 14N136B, 5600 Fishers
Lane, Rockville, MD 20857.
FOR FURTHER INFORMATION CONTACT: To
request more information on the
proposed project or to obtain a copy of
the data collection plans and draft
instruments, email paperwork@hrsa.gov
or call Lisa Wright-Solomon, the HRSA
Information Collection Clearance Officer
at (301) 443–1984.
SUPPLEMENTARY INFORMATION: When
submitting comments or requesting
information, please include the
information request collection title for
reference.
Information Collection Request Title:
Quality Bonus System Initiative
Response Form OMB No. 0906–xxxx
[New].
Abstract: The Children’s Hospitals
Graduate Medical Education (CHGME)
Payment Program provides federal
ADDRESSES:
funds to the nation’s freestanding
children’s hospitals to help them
maintain their graduate medical
education (GME) programs that train
resident physicians and dentists.
CHGME Support Reauthorization Act of
2013 states that the Secretary may
establish a Quality Bonus System (QBS),
whereby the Secretary distributes bonus
payments to hospitals participating in
the CHGME program that meet
standards specified by the Secretary. In
order to qualify for the QBS payment in
Fiscal Year (FY) 2019, CHGME award
recipients must submit documentation
as an attachment in the FY 2019
reconciliation application released in
April 2019, describing the hospital’s
initiatives, resident curriculum, and
direct resident involvement in the
following areas:
a. Integrated care models (e.g.,
integrated behavioral and mental health,
care coordination across providers and
settings);
b. Telehealth and/or Health
Information Technology;
c. Population health;
d. Social determinants of health; and
e. Additional initiatives to improve
access and quality of care to rural and/
or underserved communities.
As specified in the CHGME statute,
the QBS payment shall be remitted to
qualified hospitals participating in the
CHGME program that meet standards set
forth by the Secretary of HHS. To
demonstrate the fulfillment of such
standards, it will be necessary for
applicants to complete the QBS
Response Initiative form and submit it
as an attachment to the FY 2019
reconciliation application released in
April of 2019. This form will be used to
gather information relating to the
hospitals’ engagement in quality
initiatives.
Likely Respondents: CHGME Program
award recipients.
Burden Statement: Burden in this
context means the time expended by
persons to generate, maintain, retain,
disclose or provide the information
requested. This includes the time
needed to review instructions; to
develop, acquire, install and utilize
technology and systems for the purpose
of collecting, validating and verifying
information, processing and
maintaining information, and disclosing
and providing information; to train
personnel and to be able to respond to
a collection of information; to search
data sources; to complete and review
the collection of information; and to
transmit or otherwise disclose the
information. The total annual burden
hours estimated for this ICR are
summarized in the table below.
TOTAL ESTIMATED ANNUALIZED BURDEN HOURS
Number of
respondents
Form name
Total
responses
Average
burden per
response
(in hours)
Total burden
hours
QBS Response Initiative Form ............................................
58
1
58
32.41
1,880
Total ..............................................................................
58
........................
58
........................
1,880
HRSA specifically requests comments
on (1) the necessity and utility of the
proposed information collection for the
proper performance of the agency’s
functions, (2) the accuracy of the
estimated burden, (3) ways to enhance
the quality, utility, and clarity of the
information to be collected, and (4) the
use of automated collection techniques
or other forms of information
technology to minimize the information
collection burden.
khammond on DSK30JT082PROD with NOTICES
Number of
responses per
respondent
Amy P. McNulty,
Acting Director, Division of the Executive
Secretariat.
[FR Doc. 2018–23133 Filed 10–22–18; 8:45 am]
BILLING CODE 4165–15–P
VerDate Sep<11>2014
20:20 Oct 22, 2018
Jkt 247001
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Neurological
Disorders and Stroke
Pursuant to section 10(a) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of an
Interagency Pain Research Coordinating
Committee (IPRCC) meeting.
The meeting will be open to the
public, with attendance limited to space
available. Individuals who plan to
attend and need special assistance, such
as sign language interpretation or other
reasonable accommodations, should
notify the Contact Person listed below
in advance of the meeting.
PO 00000
Frm 00047
Fmt 4703
Sfmt 4703
Name of Committee: Interagency Pain
Research Coordinating Committee.
Date: November 16, 2018.
Time: 8:30 a.m. to 5:00 p.m. *Eastern
Time*—Approximate end time.
Agenda: The meeting will include
discussions of committee business items
including an updated Federal Pain Portfolio
Analysis, an update on the Federal Pain
Research Strategy and information about the
NIH HEAL Initiative.
Place: National Institutes of Health,
Building 35 A, Porter Neuroscience Center,
Room 620/630, 35 Convent Drive, Bethesda,
MD 20892.
Webcast Live: https://videocast.nih.gov/.
Deadlines: Submission of intent to submit
written/electronic statement for comments:
Friday, November 2, 2018. Submission of
written/electronic statement for oral
comments: Friday, November 9, 2018.
Contact Person: Linda L. Porter, Ph.D.,
Director, Office of Pain Policy & Planning,
Office of the Director, National Institute of
E:\FR\FM\23OCN1.SGM
23OCN1
Federal Register / Vol. 83, No. 205 / Tuesday, October 23, 2018 / Notices
Neurological Disorders and Stroke, NIH, 31
Center Drive, Room 8A31, Bethesda, MD
20892, Phone: (301) 451–4460, Email:
Linda.Porter@nih.gov.
Please Note: Any member of the public
interested in submitting written comments to
the Committee must notify the Contact
Person listed on this notice by 5:00 p.m. ET
on Friday, November 2, 2018, with their
request. Interested individuals and
representatives of organizations must submit
a written/electronic copy of the oral
statement/comments including a brief
description of the organization represented
by 5:00 p.m. ET on Friday, November 9,
2018. Statements submitted will be shared
with the committee members and become a
part of the public record.
The meeting will be open to the public and
accessible by live Webcast. Individuals who
participate in person or by using these
electronic services and who need special
assistance, such as captioning or other
reasonable accommodations, should submit a
request to the Contact Person listed on this
notice at least seven days prior to the
meeting.
As a part of security procedures, attendees
should be prepared to present a photo ID
during the security process to get on the NIH
campus. For a full description, please see:
https://www.nih.gov/about/
visitorsecurity.htm.
Information about the IPRCC is available
on the website: https://iprcc.nih.gov/.
Dated: October 16, 2018.
Sylvia L. Neal,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2018–23032 Filed 10–22–18; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
khammond on DSK30JT082PROD with NOTICES
National Institute on Aging; Notice of
Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute on
Aging Special Emphasis Panel; NIA AD/
ADRD Research Collaboratory.
Date: November 20, 2018.
VerDate Sep<11>2014
20:20 Oct 22, 2018
Jkt 247001
Time: 1:00 p.m. to 4:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institute on Aging,
Gateway Building, Suite 2W200, 7201
Wisconsin Avenue, Bethesda, MD 20892
(Telephone Conference Call).
Contact Person: Isis S. Mikhail, MD, MPH,
DRPH, National Institute on Aging, Gateway
Building, 7201 Wisconsin Avenue, Suite
2C212, Bethesda, MD 20892, 301–402–7704,
mikhaili@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.866, Aging Research,
National Institutes of Health, HHS)
Dated: October 17, 2018.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2018–23068 Filed 10–22–18; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Eye Institute; Notice of Closed
Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Eye Institute
Special Emphasis Panel; Secondary Data
Analysis (R21) Grant Applications.
Date: November 19, 2018.
Time: 3:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge 6700, 6700B Rockledge Drive,
Bethesda, MD 20817 (Telephone Conference
Call).
Contact Person: Brian Hoshaw, Ph.D.,
Scientific Review Officer, National Eye
Institute, National Institutes of Health,
Division of Extramural Research, 5635
Fishers Lane, Suite 1300, Rockville, MD
20892, 301–451–2020, hoshawb@
mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.867, Vision Research,
National Institutes of Health, HHS)
PO 00000
Frm 00048
Fmt 4703
Sfmt 4703
53489
Dated: October 17, 2018.
Natasha M. Copeland,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2018–23034 Filed 10–22–18; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Government-Owned Inventions;
Availability for Licensing
AGENCY:
National Institutes of Health,
HHS.
ACTION:
Notice.
The invention listed below is
owned by an agency of the U.S.
Government and is available for
licensing to achieve expeditious
commercialization of results of
federally-funded research and
development. Foreign patent
applications are filed on selected
inventions to extend market coverage
for companies and may also be available
for licensing.
FOR FURTHER INFORMATION CONTACT: Dr.
Vince Contreras, 240–669–2823;
vince.contreras@nih.gov. Licensing
information and copies of the U.S.
patent application listed below may be
obtained by communicating with the
indicated licensing contact at the
Technology Transfer and Intellectual
Property Office, National Institute of
Allergy and Infectious Diseases, 5601
Fishers Lane, Rockville, MD 20852; tel.
301–496–2644. A signed Confidential
Disclosure Agreement will be required
to receive copies of unpublished patent
applications.
SUPPLEMENTARY INFORMATION:
Technology description follows.
SUMMARY:
Fusion Glycoprotein Vaccine for
Human Metapneumovirus
Description of Technology: Human
metapneumovirus (hMPV), a negative,
single-stranded RNA virus, accounts for
approximately 5–15% of infant
respiratory tract infections and poses a
severe risk of disease and
hospitalization in both the elderly and
the immunocompromised. Investigators
at the Vaccine Research Center (VRC) of
the National Institute of Allergy and
Infectious Diseases (NIAID) have
generated an hMPV fusion glycoprotein
(‘‘F protein’’) stabilized in a prefusion
conformation.
Stabilizing this prefusion
conformation of the F protein reveals an
immunodominant site which makes it
an ideal vaccine immunogen. The
E:\FR\FM\23OCN1.SGM
23OCN1
]]>Agencies
[Federal Register Volume 83, Number 205 (Tuesday, October 23, 2018)]
[Notices]
[Pages 53488-53489]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2018-23032]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute of Neurological Disorders and Stroke
Pursuant to section 10(a) of the Federal Advisory Committee Act, as
amended, notice is hereby given of an Interagency Pain Research
Coordinating Committee (IPRCC) meeting.
The meeting will be open to the public, with attendance limited to
space available. Individuals who plan to attend and need special
assistance, such as sign language interpretation or other reasonable
accommodations, should notify the Contact Person listed below in
advance of the meeting.
Name of Committee: Interagency Pain Research Coordinating
Committee.
Date: November 16, 2018.
Time: 8:30 a.m. to 5:00 p.m. *Eastern Time*--Approximate end
time.
Agenda: The meeting will include discussions of committee
business items including an updated Federal Pain Portfolio Analysis,
an update on the Federal Pain Research Strategy and information
about the NIH HEAL Initiative.
Place: National Institutes of Health, Building 35 A, Porter
Neuroscience Center, Room 620/630, 35 Convent Drive, Bethesda, MD
20892.
Webcast Live: https://videocast.nih.gov/.
Deadlines: Submission of intent to submit written/electronic
statement for comments: Friday, November 2, 2018. Submission of
written/electronic statement for oral comments: Friday, November 9,
2018.
Contact Person: Linda L. Porter, Ph.D., Director, Office of Pain
Policy & Planning, Office of the Director, National Institute of
[[Page 53489]]
Neurological Disorders and Stroke, NIH, 31 Center Drive, Room 8A31,
Bethesda, MD 20892, Phone: (301) 451-4460, Email:
[email protected].
Please Note: Any member of the public interested in submitting
written comments to the Committee must notify the Contact Person
listed on this notice by 5:00 p.m. ET on Friday, November 2, 2018,
with their request. Interested individuals and representatives of
organizations must submit a written/electronic copy of the oral
statement/comments including a brief description of the organization
represented by 5:00 p.m. ET on Friday, November 9, 2018. Statements
submitted will be shared with the committee members and become a
part of the public record.
The meeting will be open to the public and accessible by live
Webcast. Individuals who participate in person or by using these
electronic services and who need special assistance, such as
captioning or other reasonable accommodations, should submit a
request to the Contact Person listed on this notice at least seven
days prior to the meeting.
As a part of security procedures, attendees should be prepared
to present a photo ID during the security process to get on the NIH
campus. For a full description, please see: https://www.nih.gov/about/visitorsecurity.htm.
Information about the IPRCC is available on the website: https://iprcc.nih.gov/.
Dated: October 16, 2018.
Sylvia L. Neal,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2018-23032 Filed 10-22-18; 8:45 am]
BILLING CODE 4140-01-P
